Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Neuroscience Research|May 7, 2002
Dual role for p75(NTR) signaling in survival and cell death: can intracellular mediators provide an explanation?Vidya Mamidipudi, Marie W Wooten
The Journal of Biological Chemistry|May 30, 2002
Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa BVidya Mamidipudi, Xiaoxia Li, Marie W Wooten
Molecular and Cellular Biology|July 16, 2004
RACK1 regulates G1/S progression by suppressing Src kinase activityVidya Mamidipudi, Jian Zhang, Kelly C Lee, et al.
The Journal of Biological Chemistry|December 20, 2003
Regulation of interleukin receptor-associated kinase (IRAK) phosphorylation and signaling by iota protein kinase CVidya Mamidipudi, Chunru Lin, M Lamar Seibenhener, et al.
Cellular Signalling|February 23, 2002
Nerve growth factor activates kinases that phosphorylate atypical protein kinase CMichel L Vandenplas, Vidya Mamidipudi, M Lamar Seibenhener, et al.
Biochemical and Biophysical Research Communications|November 23, 2006
Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cellsVidya Mamidipudi, Laura D Miller, Daria Mochly-Rosen, et al.
FEBS Letters|June 5, 2004
RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cellsVidya Mamidipudi, Betty Y Chang, Rachel A Harte, et al.
Cancer Chemotherapy and Pharmacology|November 29, 2011
Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cellsVidya Mamidipudi, Tao Shi, Helen Brady, et al.
British Journal of Haematology|October 1, 2010
The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanismDaniela Buglio, Vidya Mamidipudi, Noor M Khaskhely, et al.
British Journal of Haematology|August 14, 2012
Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differencesHeather E Eve, Sean Carey, Sarah J Richardson, et al.
Pageof 1